MetaCap

Neuropace (NPCE) vs Shoulder Innovations (SI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.

Summary

Shoulder Innovations (SI) has outperformed Neuropace (NPCE) over the past year, gaining 42.8% versus a gain of 19.8%. Neuropace is the larger company by market cap ($438.0 million vs $389.5 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

NPCE+18.48%SI+43.04%
+90%+35%-21%
Oct 6, 20251 yearOct 7, 2026
NPCE+41.94%SI+31.30%
+110%+41%-29%
Jul 28, 20255 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

NPCE versus SI key metrics
MetricNPCESI
Share price$12.76$18.71
Market cap$437.98M$389.52M
1-day change+0.71%-2.25%
YTD return-17.36%+30.84%
1-year return+19.81%+42.82%
5-year return-18.57%—
P/E ratio (TTM)—23.10
EPS (TTM)$-0.57$0.81
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$19.60$24.60
52-week low$9.22$10.92
Distance from 52-week high-34.90%-23.93%
Average volume169.58K117.16K
Shares outstanding34.32M20.82M
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • SI has outperformed NPCE by 23.0 percentage points over the past year.

NPCE vs SI FAQ

Which is bigger, Neuropace or Shoulder Innovations?

Neuropace (NPCE) is larger, with a market capitalization of $437.98M compared with $389.52M for Shoulder Innovations (SI).

Which stock has performed better over the past year, NPCE or SI?

SI returned +42.82% over the past 12 months, compared with +19.81% for NPCE (price return, excluding dividends). Past performance does not predict future results.

Are Neuropace and Shoulder Innovations in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons